RESEARCHER PUBLIC RESEARCH PROFILE● Verified public profile

RRK-A-5068-3530-58

David Moher

St. Michael's Hospital, University of Ottawa, University of Toronto, Ottawa Hospital, Ottawa Hospital Research Institute, Unity Health Toronto

Works1,553

Citations910,816

h-index219

i10-index811

2-year citedness23.86

Mean FWCI*178.72

Top 1%*19

Top 10%*24

*Calculated from the leading research works available to the ResearchRank profile service.

IDORCID ▥Research data✓Verify credentials

ResearchRank IDRRK-A-5068-3530-58

Observed nameDavid Moher

ORCID0000-0003-2434-4206

Current / last-known institutionSt. Michael's Hospital, University of Ottawa, University of Toronto, Ottawa Hospital, Ottawa Hospital Research Institute, Unity Health Toronto

Research topicsMeta-analysis and systematic reviews · Academic Publishing and Open Access · Clinical practice guidelines implementation · Delphi Technique in Research · Statistical Methods in Clinical Trials

Name variantsD MOHER, D Moher, D. MOHER, D. Moher, DAVID MOHER, David MOHER, David Moher, David Moher*, Moher, Moher, D, Moher, D., Moher, David

FULL PROFILE ANALYSIS

David Moher - detailed research intelligence

Identity, scholarly output, impact indicators, affiliations, topics and publication evidence for this ResearchRank record.

Profile typeResearcher

Works1,553

Citations910,816

h-index219

i10-index811

Current / last-known affiliationSt. Michael's Hospital, University of Ottawa, University of Toronto, Ottawa Hospital, Ottawa Hospital Research Institute, Unity Health Toronto

ORCID0000-0003-2434-4206

Name variantsD MOHER, D Moher, D. MOHER, D. Moher, DAVID MOHER, David MOHER, David Moher, David Moher*, Moher, Moher, D, Moher, D., Moher, David

Primary research topics

Meta-analysis and systematic reviewsAcademic Publishing and Open AccessClinical practice guidelines implementationDelphi Technique in ResearchStatistical Methods in Clinical Trials

RESEARCH ACHIEVEMENT SNAPSHOT

Evidence-backed profile highlights

This public profile presents scholarly evidence and recognition indicators without displaying certificate prices or checkout controls.

✓ Evidence threshold met

Verified Researcher Certificate

Active ResearchRank profile with at least one indexed scholarly output

✓ Evidence threshold met

Research Output Certificate

At least 10 indexed scholarly works

✓ Evidence threshold met

Citation Impact Certificate

At least 100 indexed citations

✓ Evidence threshold met

h-index Achievement Certificate

h-index of 10 or higher

✓ Evidence threshold met

Distinguished Researcher Certificate

h-index of 20+ and at least 1,000 indexed citations

✓ Evidence threshold met

Sustained Research Output Certificate

At least 50 indexed scholarly outputs

✓ Evidence threshold met

Distinguished Research Impact Certificate

At least 5,000 indexed citations and h-index of 30+

Public profile: Research metrics and recognition evidence are shown for professional sharing. Commercial pricing and registration controls are intentionally omitted.

Extended publication analytics and related-profile intelligence are loading in the background. The full profile details below remain available even if the live analytics service is temporarily slow.

TOP-CITED OUTPUT

Research works

Full profile view · up to 25 leading works

The PRISMA 2020 statement: an updated guideline for reporting systematic reviewsReview · 2021 · 107,998 citations · Open access · FWCI 522.6212 · Full text ↗

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statementReview · 2009 · 83,823 citations · Open access · FWCI 54.0925 · Full text ↗

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA StatementReview · 2009 · 64,004 citations · Open access · FWCI 19.2031 · Full text ↗

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.Review · 2009 · 44,859 citations · Open access · FWCI 46.6689 · Full text ↗

PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and ExplanationArticle · 2018 · 43,496 citations · Open access · FWCI 1042.0731 · Full text ↗

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA StatementReview · 2009 · 37,552 citations · FWCI 16.6224 · Full text ↗

The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsArticle · 2011 · 33,790 citations · Open access · FWCI 356.0289 · Full text ↗

The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and ElaborationReview · 2009 · 28,100 citations · Open access · FWCI 31.1196 · Full text ↗

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statementReview · 2015 · 26,219 citations · Open access · FWCI 156.9317 · Full text ↗

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA StatementReview · 2009 · 19,575 citations · Open access · FWCI 12.6057 · Full text ↗

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaborationReview · 2009 · 17,632 citations · Open access · FWCI 11.6635 · Full text ↗

The PRISMA 2020 statement: an updated guideline for reporting systematic reviewsReview · 2021 · 13,863 citations · Open access · FWCI 83.7753 · Full text ↗

CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trialsArticle · 2010 · 13,367 citations · Open access · FWCI 630.2047 · Full text ↗

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanationReview · 2015 · 13,117 citations · Open access · FWCI 94.3688 · Full text ↗

Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statementReview · 2010 · 12,152 citations · FWCI 22.5198 · Full text ↗

The PRISMA 2020 statement: An updated guideline for reporting systematic reviewsReview · 2021 · 11,703 citations · Open access · FWCI 82.0348 · Full text ↗

PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviewsReview · 2021 · 11,692 citations · Open access · FWCI 67.5476 · Full text ↗

AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or bothReview · 2017 · 10,630 citations · Open access · FWCI 89.0691 · Full text ↗

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaborationReview · 2009 · 10,574 citations · Open access · FWCI 6.2492 · Full text ↗

Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guideArticle · 2014 · 10,536 citations · Open access · FWCI 316.7718 · Full text ↗

The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and ElaborationReview · 2009 · 10,349 citations · FWCI 8.6781 · Full text ↗

CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trialsArticle · 2010 · 9,327 citations · Open access · FWCI 232.9667 · Full text ↗

CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trialsArticle · 2010 · 8,882 citations · Open access · FWCI 346.7951 · Full text ↗

The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and ExplanationsReview · 2015 · 8,269 citations · FWCI 38.5979 · Full text ↗

The PRISMA 2020 statement: an updated guideline for reporting systematic reviewsPreprint · 2020 · 8,071 citations · Open access · Full text ↗